Association of catechol-O-methyl transferase (COMT) gene -287A/G polymorphism with susceptibility to obsessive-compulsive disorder in Chinese Han population

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 4, 2011, Pages 393-400

  Liu, Shiguo ^a   Liu, Yanhui ^a,b   Wang, Haiping ^a   Zhou, Ruiling ^c   Zong, Jinbao ^a   Li, Changgui ^a   Zhang, Xinhua ^a   Ma, Xu ^d,e,f  

^a QINGDAO UNIVERSITY   (China)

^b Binzhou Youfu Hospital   (China)

^c PEOPLE S HOSPITAL OF RIZHAO   (China)

^d GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^e NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

COMT 287A G polymorphism; Genotype and phenotype; OCD; Principal component analysis

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHINA; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; PRINCIPAL COMPONENT ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 79955116718     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31173     Document Type: Article

References (49)

1. Baer L. 1994. Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. J Clin Psychiatry 55 (Suppl): 18-23.
2. Bellodi L, Sciuto G, Diaferia G, et al. 1992. Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res 42:111-120.
3. Black DW, Monahan P, Gable J, et al. 1998. Hoarding and treatment response in 38 nondepressed subjects with obsessive-compulsive disorder. J Clin Psychiatry 59:420-425.
4. Camarena B, Rinetti G, Cruz C, et al. 2001. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet 105:279-282.
5. Cao L, Li T, Liu X. 2003. Association study of heroin dependence and catechol-O-methyltransferase gene. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20:127-130.
6. The Clomipramine Collaborative Study Group. 1991, Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 48:730-738.
7. Chen J, Lipska BK, Halim N, et al. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
8. Chouinard G. 1992. Sertraline in the treatment of obsessive compulsive disorder: Two double-blind, placebo-controlled studies. Int Clin Psychopharmacol 7 (Suppl 2): 37-41.
9. Cullen B, Brown CH, Riddle MA, et al. 2007. Factor analysis of the Yale-Brown Obsessive Compulsive Scale in a family study of obsessive-compulsive disorder. Depress Anxiety 24:130-138.
10. Denys D, Van Nieuwerburgh F, Deforce D, et al. 2006. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. Eur Neuropsychopharmacol 16:446-450.
11. Erdal ME, Tot S, Yazici K, et al. 2003. Lack of association of catechol-O-methyltransferase gene polymorphism in obsessive-compulsive disorder. Depress Anxiety 18:41-45.
12. Feinstein SB, Fallon BA, Petkova E, et al. 2003. Item-by-item factor analysis of the Yale-Brown Obsessive Compulsive Scale Symptom Checklist. J Neuropsychiatry Clin Neurosci 15:187-193.
13. Fontenelle LF, Hasler G. 2008. The analytical epidemiology of obsessive-compulsive disorder: Risk factors and correlates. Prog Neuropsychopharmacol Biol Psychiatry 32:1-15.
14. Frisch A, Michaelovsky E, Rockah R, et al. 2000. Association between obsessive-compulsive disorder and polymorphisms of genes encoding components of the serotonergic and dopaminergic pathways. Eur Neuropsychopharmacol 10:205-209.
15. Funke B, Malhotra AK, Finn CT, et al. 2005. COMT genetic variation confers risk for psychotic and affective disorders: A case control study. Behav Brain Funct 1:19.
16. Grossman MH, Emanuel BS, Budarf ML. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2. Genomics 12:822-825.
17. Han L, Nielsen DA, Rosenthal NE, et al. 1999. No coding variant of the tryptophan hydroxylase gene detected in seasonal affective disorder, obsessive-compulsive disorder, anorexia nervosa, and alcoholism. Biol Psychiatry 45:615-619.
18. Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al. 2002. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 114:541-552.
19. Hasler G, Pinto A, Greenberg BD, et al. 2007. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study. Biol Psychiatry 61:617-625.
20. Hemmings SM, Stein DJ. 2006. The current status of association studies in obsessive-compulsive disorder. Psychiatr Clin North Am 29:411-444.
21. Hemmings SM, Kinnear CJ, Niehaus DJ, et al. 2003. Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder. Eur Neuropsychopharmacol 13:93-98.
22. Hu XZ, Lipsky RH, Zhu G, et al. 2006. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815-826.
23. Inouye E. 1965. Similar and dissimilar manifestations of obsessive-compulsive neuroses in monozygotic twins. Am J Psychiatry 121:1171-1175.
24. Karayiorgou M, Altemus M, Galke BL, et al. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572-4575.
25. Karayiorgou M, Sobin C, Blundell ML, et al. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
26. Katerberg H, Cath DC, Denys DA, et al. 2010. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder. Am J Med Genet Part B 153B:167-176.
27. Lachman HM, Papolos DF, Saito T, et al. 1996. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
28. Leckman JF, Grice DE, Boardman J, et al. 1997. Symptoms of obsessive-compulsive disorder. Am J Psychiatry 154:911-917.
29. Mataix-Cols D, Rauch SL, Manzo PA, et al. 1999. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Am J Psychiatry 156:1409-1416.
30. Mataix-Cols D, Rauch SL, Baer L, et al. 2002. Symptom stability in adult obsessive-compulsive disorder: Data from a naturalistic two-year follow-up study. Am J Psychiatry 159:263-268.
31. Mataix-Cols D, Rosario-Campos MC, Leckman JF. 2005. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162:228-238.
32. McDougle CJ, Epperson CN, Price LH, et al. 1998. Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3:270-273.
33. Meira-Lima I, Shavitt RG, Miguita K, et al. 2004. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav 3:75-79.
34. Nicolini H, Cruz C, Camarena B, et al. 1996. DRD2, DRD3 and 5HT2A receptor genes polymorphisms in obsessive-compulsive disorder. Mol Psychiatry 1:461-465.
35. Niehaus DJ, Kinnear CJ, Corfield VA, et al. 2001. Association between a catechol-o-methyltransferase polymorphism and obsessive-compulsive disorder in the Afrikaner population. J Affect Disord 65:61-65.
36. Nothen MM, Propping P, Fimmers R. 1993. Association versus linkage studies in psychosis genetics. J Med Genet 30:634-637.
37. Nurnberger JI Jr, Blehar MC, Kaufmann CA, et al. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859; discussion 863-4.
38. Ohara K, Nagai M, Suzuki Y, et al. 1998. No association between anxiety disorders and catechol-O-methyltransferase polymorphism. Psychiatry Res 80:145-148.
39. Pauls DL, Alsobrook JP II, Goodman W, et al. 1995. A family study of obsessive-compulsive disorder. Am J Psychiatry 152:76-84.
40. Pinto A, Eisen JL, Mancebo MC, et al. 2007. Taboo thoughts and doubt/checking: A refinement of the factor structure for obsessive-compulsive disorder symptoms. Psychiatry Res 151:255-258.
41. Pooley EC, Fineberg N, Harrison PJ. 2007. The met(158) allele of catechol-O-methyltransferase (COMT) is associated with obsessive-compulsive disorder in men: Case-control study and meta-analysis. Mol Psychiatry 12:556-561.
42. Poyurovsky M, Michaelovsky E, Frisch A, et al. 2005. COMT Val158Met polymorphism in schizophrenia with obsessive-compulsive disorder: A case-control study. Neurosci Lett 389:21-24.
43. Purcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150.
44. Samuels J, Bienvenu OJ III, Riddle MA, et al. 2002. Hoarding in obsessive compulsive disorder: Results from a case-control study. Behav Res Ther 40:517-528.
45. Saxena S, Maidment KM, Vapnik T, et al. 2002. Obsessive-compulsive hoarding: Symptom severity and response to multimodal treatment. J Clin Psychiatry 63:21-27.
46. Saxena S, Brody AL, Maidment KM, et al. 2007. Paroxetine treatment of compulsive hoarding. J Psychiatr Res 41:481-487.
47. Schindler KM, Richter MA, Kennedy JL, et al. 2000. Association between homozygosity at the COMT gene locus and obsessive compulsive disorder. Am J Med Genet 96:721-724.
48. Shugart YY, Samuels J, Willour VL, et al. 2006. Genomewide linkage scan for obsessive-compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11:763-770.
49. Walitza S, Wewetzer C, Warnke A, et al. 2002. 5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disorders. Mol Psychiatry 7:1054-1057.